Uncategorized
FDA approves Trulign toric accommodating IOL
The Trulign toric accommodating posterior chamber IOL has been approved by the U.S. Food and Drug Administration, according to a news release from Bausch + Lomb.The lens, which corrects for astigmatism and can improve vision across a natural range of focus, is meant for primary implantation in the capsular bag for visual correction of aphakia, as well as postoperative refractive astigmatism secondary to the removal of a cataractous lens, the release said.